Literature DB >> 11483753

Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep.

M Reichert1, A Winnicka, L Willems, R Kettmann, G H Cantor.   

Abstract

The cytoplasmic tail of bovine leukemia virus (BLV) transmembrane protein gp30 has multiple amino acid motifs that mimic those present in signaling proteins associated with B-cell and T-cell receptors. The proline-rich motif of gp30, PX(2)PX(4-5)P, is analogous to the recognition site of Src homology 3 (SH3) domains of signaling molecules. Using site-directed mutagenesis of an infectious molecular clone of BLV, point mutations were introduced which changed three of the prolines of the motif to alanines. The influence of these mutations on the pathogenicity of BLV was studied in sheep which received either (i) plasmid DNA with provirus containing proline-to-alanine mutations (pppBLV), (ii) plasmid DNA with wild-type provirus (wtBLV), or (iii) transfection reagent alone. Although all of the BLV-injected animals seroconverted at approximately the same time, viral loads at later time points were high in five of five of the wtBLV group and two of five of the pppBLV group but low in three of five of the pppBLV group, as determined by semiquantitative PCR. Viral expression was lower in the pppBLV-transfected sheep, as measured by p24 antigen enzyme-linked immunosorbent assay in cultured cells, and serologic titers were lower. Thirty-one months after transfection, four of four wtBLV-transfected sheep had died of leukemia and lymphoma, and all five of the pppBLV-transfected sheep were clinically healthy and had normal peripheral blood lymphocyte counts. These data indicate that the proline-rich motif of gp30 is not required for viral infectivity but is important for high viral load in vivo, suggesting that SH3-mediated gp30 interactions are critical for viral pathogenesis following infection. Absence of interactions with the proline-rich motif may prevent or delay tumorigenesis in sheep.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483753      PMCID: PMC115052          DOI: 10.1128/jvi.75.17.8082-8089.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

Review 1.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

2.  A potential proline-rich motif upstream of the immunoreceptor tyrosine-based activation motif in bovine leukemia virus gp30, Epstein-Barr virus LMP2A, herpesvirus papio LMP2A, and African horsesickness virus VP7.

Authors:  G H Cantor
Journal:  Virology       Date:  1996-06-15       Impact factor: 3.616

3.  Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.

Authors:  D Portetelle; M Mammerickx; A Burny
Journal:  J Virol Methods       Date:  1989-02       Impact factor: 2.014

Review 4.  Molecular glue: kinase anchoring and scaffold proteins.

Authors:  M C Faux; J D Scott
Journal:  Cell       Date:  1996-04-05       Impact factor: 41.582

5.  Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis.

Authors:  F Dequiedt; E Hanon; P Kerkhofs; P P Pastoret; D Portetelle; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  In vivo transfection of bovine leukemia provirus into sheep.

Authors:  L Willems; D Portetelle; P Kerkhofs; G Chen; A Burny; M Mammerickx; R Kettmann
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

9.  Proliferating cell nuclear antigen expression in sheep infected with bovine leukemia virus.

Authors:  N Hailata; R Johnson; F al-Bagdadi; S Hanash
Journal:  Vet Immunol Immunopathol       Date:  1995-02       Impact factor: 2.046

10.  The (YXXL/I)2 signalling motif found in the cytoplasmic segments of the bovine leukaemia virus envelope protein and Epstein-Barr virus latent membrane protein 2A can elicit early and late lymphocyte activation events.

Authors:  P Beaufils; D Choquet; R Z Mamoun; B Malissen
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more
  10 in total

1.  Binding of cellular p32 protein to the rubella virus P150 replicase protein via PxxPxR motifs.

Authors:  Suganthi Suppiah; Heather A Mousa; Wen-Pin Tzeng; Jason D Matthews; Teryl K Frey
Journal:  J Gen Virol       Date:  2012-01-13       Impact factor: 3.891

2.  Proteome analysis of sheep B lymphocytes in the course of bovine leukemia virus-induced leukemia.

Authors:  Michal Reichert
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-24

3.  Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface.

Authors:  Sinisa Novakovic; Earl T Sawai; Kathryn Radke
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 4.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

5.  Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.

Authors:  Elizabeth R Johnston; Lorraine M Albritton; Kathryn Radke
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Phylogenetic Analysis of South African Bovine Leukaemia Virus (BLV) Isolates.

Authors:  Akiko Suzuki; Rosamund Chapman; Nicola Douglass; Olivia Carulei; Johan van Rensburg; Anna-Lise Williamson
Journal:  Viruses       Date:  2020-08-17       Impact factor: 5.048

7.  Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).

Authors:  Seong In Lim; Wooseog Jeong; Dong Seob Tark; Dong Kun Yang; Chang Hee Kweon
Journal:  J Vet Sci       Date:  2009-12       Impact factor: 1.603

Review 8.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

9.  Characterization of an envelope gene VP19 from Singapore grouper iridovirus.

Authors:  Xiaohong Huang; Jie Gong; Youhua Huang; Zhengliang Ouyang; Shaowen Wang; Xiuli Chen; Qiwei Qin
Journal:  Virol J       Date:  2013-12-16       Impact factor: 4.099

10.  Genotypes diversity of env gene of Bovine leukemia virus in Western Siberia.

Authors:  Natalia Blazhko; Sultan Vyshegurov; Alexander Donchenko; Kirill Shatokhin; Valeria Ryabinina; Kirill Plotnikov; Alevtina Khodakova; Sergey Pashkovskiy
Journal:  BMC Genet       Date:  2020-10-22       Impact factor: 2.797

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.